Thomas E. Powell Sells 5,200 Shares of Teleflex Incorporated (NYSE:TFX) Stock
Teleflex Incorporated (NYSE:TFX) insider Thomas E. Powell sold 5,200 shares of Teleflex stock in a transaction dated Friday, November 9th. The shares were sold at an average price of $264.82, for a total transaction of $1,377,064.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Teleflex stock traded down $11.41 during midday trading on Friday, reaching $256.64. 263,083 shares of the stock traded hands, compared to its average volume of 212,666. The company has a quick ratio of 1.51, a current ratio of 2.26 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $12.33 billion, a price-to-earnings ratio of 30.55, a PEG ratio of 2.16 and a beta of 1.14. Teleflex Incorporated has a fifty-two week low of $227.52 and a fifty-two week high of $288.78.
Teleflex (NYSE:TFX) last posted its earnings results on Thursday, November 1st. The medical technology company reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.41 by $0.11. Teleflex had a net margin of 2.81% and a return on equity of 18.04%. The firm had revenue of $609.70 million during the quarter, compared to analyst estimates of $609.05 million. During the same period in the previous year, the business posted $2.12 EPS. Teleflex’s revenue was up 14.0% on a year-over-year basis. Research analysts expect that Teleflex Incorporated will post 9.91 earnings per share for the current year.
Several hedge funds have recently added to or reduced their stakes in the business. Legal & General Group Plc raised its position in shares of Teleflex by 0.4% during the 3rd quarter. Legal & General Group Plc now owns 212,411 shares of the medical technology company’s stock worth $56,521,000 after buying an additional 933 shares in the last quarter. Nordea Investment Management AB raised its position in shares of Teleflex by 32.6% during the 3rd quarter. Nordea Investment Management AB now owns 1,763 shares of the medical technology company’s stock worth $469,000 after buying an additional 433 shares in the last quarter. Beaton Management Co. Inc. bought a new stake in shares of Teleflex during the 3rd quarter worth about $213,000. Redhawk Wealth Advisors Inc. bought a new stake in shares of Teleflex during the 3rd quarter worth about $450,000. Finally, Mastrapasqua Asset Management Inc. raised its position in shares of Teleflex by 6.8% during the 3rd quarter. Mastrapasqua Asset Management Inc. now owns 12,390 shares of the medical technology company’s stock worth $3,297,000 after buying an additional 790 shares in the last quarter. Institutional investors own 92.42% of the company’s stock.
Several research firms have recently commented on TFX. TheStreet raised shares of Teleflex from a “c+” rating to a “b-” rating in a report on Wednesday, November 28th. ValuEngine raised shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, September 13th. Needham & Company LLC reaffirmed a “buy” rating and issued a $315.00 price target on shares of Teleflex in a report on Friday, November 2nd. UBS Group started coverage on shares of Teleflex in a research note on Tuesday, November 27th. They set a “buy” rating and a $310.00 target price for the company. Finally, Piper Jaffray Companies boosted their target price on shares of Teleflex to $310.00 and gave the company an “overweight” rating in a research note on Friday, November 2nd. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $291.67.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.
Featured Article: Risk Tolerance and Your Investment Decisions
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.